“showed a trend”

MV miR-21 levels correlated positively with tumor size ( P = 0.04) and showed a trend toward correlation with carcinoma embryonic antigen levels ( P = 0.08).

Animals treated with RGB+KA also had steady GluR1 levels at this time; however, the ventral granule cell layer (VGCL) showed a trend of decline at 87.9 ± 7.2% of the control ( p =0.08).

The accuracy rate and number of CPR experiences showed a trend of negative association (P=0.08).

Pooling data from combined PB and WP treatments showed a trend for greater change in LBM from baseline to 12 wk compared with MDP treatment (0.69 kg; 95% CI: −0.08, 1.46 kg; P = 0.08).

mRNA expression of collagen type I α 1 chain (COL1A1) showed a trend in being up-regulated following TGF-β1 treatment with mean FC = 4.8 ( P = 0.08) for control fibroblasts ( Figure 6 L) and mean FC = 6.6 ( P = 0.09) for IPF fibroblasts ( Figure 6 L) compared with corresponding untreated fibroblasts (FC = 1). α-Smooth muscle actin (encoded by gene ACTA2 ), a component of the cytoskeleton, is a marker of fibroblast activation to a contractile, ECM-producing phenotype.

Similarly, lack of an MDT steroid plan was significantly linked to Grade 3 complications ( p = 0.01) and showed a trend for Grade 2 ( p = 0.08) but was not associated with Grade 1 toxicity ( p = 0.56).

RMG showed a trend to be lower in LP compared to NP (p<0.08) at PND 10 and 12.

Post hoc tests showed a trend for reduced proportion of intermediate monocytes in the exercising patients (7.58 ± 1.68% to 6.38 ± 1.81%; P = 0.08, ES = 0.68), and an increase in non-exercising HD patients (6.86 ± 1.45% to 7.88 ± 1.66%; P = 0.02, ES = 0.65).

Moreover, IL-4 treatment showed a trend ( p = 0.080) toward an increase in TG2 protein level (Fig. 1 e).

Two RCTs showed similar efficacy between EBL and EVO for treating GOV1 bleeding [ 201 , 231 ], another RCT showed a trend toward higher hemostasis rate in the EVO group compared to the EBL group (85% vs. 43%, P =0.08) [ 44 ].

Our results showed a trend toward a 4% increase in the NAA/tCr ratio between sham and tDCS conditions ( p = 0.08, Cohen’s d = 0.52) and no significant changes in any other metabolite ratios ( Fig 3 , Table 2 ).

Patients receiving long-term AC showed a trend towards higher PVT regression rates (58% vs. 28% in patients receiving vs. not receiving long-term AC; p = 0.08).

TGF-β1 showed a trend for higher levels in Loeys-Dietz syndrome, Marfan syndrome, BAV with coarctation, and Turner syndrome (p = 0.08, Kruskal-Wallis analysis).

The interaction between condition and adherence showed a trend of statistical significance, F (1,12) = 3.65, p = 0.080, which means that visual imagery (QMI) could be a moderator of the effect of the condition on adherence, accounting for 13.98% of the variance.

However, the estimated mean contents in the positive cases (including samples positive after enrichment), only showed a trend ( P = 0.08) towards lower Salmonella loads in the MCFA group (122 ± 67 CFU/g) compared to the CTRL group (1,950 ± 6,901 CFU/g).

VO 2peak also showed a trend to improvement at 3 months ( p = 0.08), but this was not seen at 6 months ( p = 0.27) (Tables 2 and 3 ).

Active individuals with uncontrolled BP levels showed a trend (p = 0.08) of 17% higher risk of all-cause mortality compared to their peers with controlled BP levels.

Mixed results were found on lung function parameters, and a meta-analysis including two studies with comparable methodology showed a trend towards reduced maximum flow rate at functional residual capacity of −34.59 mL/s (95% CI −72.81 to 3.63, p=0.08) in 1-month-old infants born to women who smoked during pregnancy.

The induction of T-cell neoplasms in male mice in the 1 W group also showed a trend toward earlier rather than late-onset B-cell neoplasm ( P = 0.08) (Table 2), due to the fact that several T-cell neoplasm-bearing mice died relatively late ( Supplementary Fig.

In a post hoc analysis of patients in advanced stage, a significant PFS advantage was observed in patient who had received ibrutinib ( P = 0.03), who showed a trend for OS advantage ( P = 0.08).

Mean f values showed a trend towards the difference between the groups ( p = 0.08).

However, there were significant differences in the domains physical health (p = 0.04, Cohen’s d [d] = -0.42), marriage (p = 0.01, d = 1.31), and friends (p = 0.04, d = -0.41), and life as a whole showed a trend to difference (p = 0.08, d = -0.33).

This combined parameter showed a trend of potentially acting as an independent negative prognosticator ( p = 0.08) ( Table S1 ). 3.

Janus kinase 2a (encoding a homolog of mammalian JAK2) showed a trend toward a decrease ( p = 0.08), and stat1a and stat1b were not significantly altered by GTE administration.

Maximal aerobic capacity assessed in the lab showed a trend for a negative relationship with age [rs(23) = −0.38, p = 0.08] ( Figure 1 ).